Division of Pediatric Endocrinology, Department of Pediatrics, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, CMSC 406, Baltimore, Maryland 21208, USA.
J Mol Endocrinol. 2011 Jun 9;46(3):R93-R102. doi: 10.1530/JME-10-0133. Print 2011 Jun.
The pituitary gland produces hormones that play important roles in both the development and the homeostasis of the body. A deficiency of two or several of these pituitary hormones, known as combined pituitary hormone deficiency, may present in infants or children due to an unknown etiology and is considered congenital or idiopathic. Advancements in our understanding of pituitary development have provided a genetic basis to explain the pathophysiological basis of pituitary hormone disease. Nevertheless, there are several challenges to the precise characterization of abnormal genotypes; these exist secondary to the complexities of several of the hypothalamic/pituitary developmental factors and signals, which ultimately integrate in a temporal and spatial dependent manner to produce a mature gland. Furthermore, the clinical presentation of pituitary hormone disease may be dynamic as subsequent hormone deficiencies may develop over time. The characterization of patients with mutations in genes responsible for pituitary development provides an opportunity to discover potential novel mechanisms responsible for pituitary pathophysiology. The focus of this review is to report the most recent mutations in genes responsible for pituitary development in patients with hypopituitarism and emphasize the importance to physicians and researchers for characterizing these patients. Continuing efforts toward understanding the molecular basis of pituitary development as well as genetic screening of patients with pituitary disease will offer new insights into both diagnostic and potential therapeutic options that will decrease the morbidity and mortality in patients with hypopituitarism.
垂体腺产生的激素在人体的发育和稳态中都起着重要作用。由于未知病因,两种或多种垂体激素的缺乏,即联合垂体激素缺乏症,可能会在婴儿或儿童中出现,被认为是先天性或特发性的。我们对垂体发育的认识的进步为解释垂体激素疾病的病理生理基础提供了遗传基础。然而,精确描述异常基因型仍然存在一些挑战;这些是由于下丘脑/垂体发育因子和信号的复杂性所致,这些因子和信号最终以时空依赖的方式整合,产生成熟的腺体。此外,垂体激素疾病的临床表现可能是动态的,因为随着时间的推移可能会出现其他激素缺乏。对导致垂体发育的基因突变的患者进行特征描述为发现负责垂体病理生理学的潜在新机制提供了机会。这篇综述的重点是报告在垂体功能减退症患者中与垂体发育相关的基因的最新突变,并强调了对医生和研究人员对这些患者进行特征描述的重要性。继续努力了解垂体发育的分子基础以及对垂体疾病患者进行基因筛查,将为诊断和潜在治疗选择提供新的见解,从而降低垂体功能减退症患者的发病率和死亡率。